Карпов О.И., Зайцев А.А. Риск применения лекарств при беременности и лактации // СПб.: БХВ, 1998. - 352 с.
Addis A., Sharabi S., Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? // Drug Saf. - 2000. - Vol. 23. - P. 245-253.
Australian Drug Evaluation Committee. Medicines in pregnancy. An Australian Categorization of Risk, 1992.
Drugs in pregnancy and lactation (4-th edition) // Ed. Gerald G. Biggs, Roger K. Freeman, Summer J. Yaffe - Williams & Wilkins, 1994. - P. 975.
FASS. Classification of medical products for use during pregnancy and lactation. The Swedish system // Stockholm: LINFO, Drug Information Ltd, 1993.
Loebstein R., Lalkin A., Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. // Clin. Pharmacokinet. - 1997. - Vol. 33. - P. 328-343.
Oakley C., Child A., Iung B., Prebitero P., Tornos P. For the Task force on the management of cardiovascular disease during pregnancy on European Society of Cardiology. Expert consensus document on management of cardiovascular disease during pregnancy // Eur. Heart J. - 2003. - Vol. 24. - P. 761-781.
U.S. Food and Drug Administration Center for Drug Evaluation and Research. Guidance to industry: establishing pregnancy registries. Draft Guidance. June 1999.
Weiss S.R. Prescription Medication Use in Pregnancy // Medscape Pharmacotherapy. - 2000. - Vol. 2 (2).